Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$144.95 - $152.29 $374,695 - $393,669
-2,585 Reduced 4.04%
61,357 $9.28 Million
Q2 2022

Aug 15, 2022

SELL
$83.14 - $145.99 $886,106 - $1.56 Million
-10,658 Reduced 14.29%
63,942 $9.32 Million
Q1 2022

May 13, 2022

SELL
$110.08 - $142.92 $10.5 Million - $13.6 Million
-95,371 Reduced 56.11%
74,600 $8.85 Million
Q4 2021

Feb 11, 2022

BUY
$99.73 - $148.48 $9.98 Million - $14.9 Million
100,071 Added 143.16%
169,971 $23.4 Million
Q2 2021

Aug 12, 2021

BUY
$65.78 - $105.02 $335,478 - $535,602
5,100 Added 7.87%
69,900 $6.79 Million
Q1 2021

May 17, 2021

SELL
$64.07 - $91.75 $2.73 Million - $3.91 Million
-42,637 Reduced 39.69%
64,800 $4.43 Million
Q4 2020

Feb 03, 2021

SELL
$65.07 - $98.24 $546,588 - $825,216
-8,400 Reduced 7.25%
107,437 $9.21 Million
Q2 2020

Aug 12, 2020

SELL
$29.01 - $74.23 $1.85 Million - $4.73 Million
-63,756 Reduced 35.5%
115,837 $8.47 Million
Q1 2020

May 06, 2020

BUY
$27.51 - $57.29 $656,498 - $1.37 Million
23,864 Added 15.32%
179,593 $6.11 Million
Q4 2019

Feb 14, 2020

BUY
$40.86 - $57.65 $1.33 Million - $1.88 Million
32,573 Added 26.45%
155,729 $8.48 Million
Q3 2019

Nov 12, 2019

BUY
$37.38 - $49.47 $1.24 Million - $1.64 Million
33,200 Added 36.91%
123,156 $5.14 Million
Q2 2019

Aug 14, 2019

SELL
$39.79 - $67.01 $2.58 Million - $4.34 Million
-64,744 Reduced 41.85%
89,956 $3.94 Million
Q1 2019

May 13, 2019

BUY
$34.52 - $53.29 $331,392 - $511,584
9,600 Added 6.62%
154,700 $7.96 Million
Q4 2018

Feb 11, 2019

SELL
$29.75 - $42.9 $92,225 - $132,990
-3,100 Reduced 2.09%
145,100 $5.37 Million
Q3 2018

Nov 14, 2018

BUY
$32.79 - $43.0 $3.8 Million - $4.98 Million
115,900 Added 358.82%
148,200 $5.57 Million
Q1 2018

May 07, 2018

BUY
$22.49 - $34.56 $726,427 - $1.12 Million
32,300 New
32,300 $832,000
Q4 2017

Feb 08, 2018

SELL
$20.44 - $35.56 $143,080 - $248,920
-7,000 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$23.54 - $38.21 $164,780 - $267,470
7,000
7,000 $262,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.